Protagonist Therapeutics Inc. (PTGX) dipped -10.26% or -0.9 to $7.87. It is close to 54054 shares traded, which is 63.67% compare to the average total volume 84896. The market cap of PTGX is $190.34 million. The year to date change is -68.8%. The 52 week price range is from $5.5 to $23.97. Price of PTGX have changed -6.40% during last week. It have changed -0.57% over last month, -3.20% over last 3 months, 46.17% over last 6 months and -52.75% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 8.83. It is 12.20% above current price. The 200-day Moving Averages for PTGX is 10.19. It is 29.48% above current price. The 52-week High is 23.97. It is 204.57% from the current price. The 52-week Low is 5.5. It is -30.11% from current price.
There are some statistics of PTGX. It is has market cap $190.34 million. The share outstanding is 24.19 million. The average volume is 84896. The percent of top 15 Institution holding is 90.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -30.93%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -21.68%.